current and future trends in immunotherapy for msi-h colorectal cancer
Published 1 year ago • 273 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
1:38
immuno-oncology in msi colorectal cancer
-
1:25
neoadjuvant immunotherapy in msi-high colorectal cancer
-
1:08
the role of neoadjuvant immunotherapy in msi-high gastric cancer
-
9:24
msi status and immunotherapy in advanced colorectal cancer
-
2:36
immunotherapy in gynecological cancers: current and future landscape
-
1:57
the emerging role of ctdna as a predicative marker in dmmr/msi-h colorectal cancer
-
1:12
the future of immunotherapy in mmr proficient colorectal cancer
-
3:32
bintrafusp alfa in msi-h cancers following progression on immunotherapy
-
0:43
immunotherapy in msi-h/dmmr mcrc: first-line options and dual checkpoint inhibition insights
-
0:41
how can immunotherapies successfully target mss colorectal cancer?
-
1:27
msi as a key immunotherapy biomarker in colon cancer
-
5:49
immunotherapy and msi status in colorectal cancer
-
0:24
how can we incorporate checkpoint inhibition in microsatellite stable colorectal cancer?
-
0:43
keynote-177 and checkmate 8hw: promising first-line immunotherapy for msi-h mcrc
-
2:55
analysis of hla gene expression in dmmr/msi-h, ici-resistant crc
-
5:26
current trends in the treatment of crc
-
2:49
5 current trends of cancer immunotherapy 2022 i atlantis bioscience
-
1:11
checkmate-8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
4:00
immunotherapy combinations in msi and mss mcrc